Genetic data from familiar PAH patients and expression data from the idiopathic PAH patient population provide substantial evidence of reduced BMPR2 signaling as a driver of pathological vascular remodeling in PAH [24]. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.